The Latest Cardiac and Vascular News
SynCardia Manufactures and Distributes the First-and-Only Commercially Available and FDA Approved Total Artificial Heart SynCardia is Entering a Rapid Growth Phase Supported by New Product Development, Label Expansion, and International Growth Transaction Estimates a Pre-Money Enterprise Value of $480 Million for Picard Medical Picard Medical Stockholders Will Roll 100% of Their Existing […]
Five grant recipients announced at Annual Meeting Chicago, IL, April 22, 2023 (GLOBE NEWSWIRE) — The International Society for Heart and Lung Transplantation (ISHLT) announced more than $400,000 USD in funding for research designed to improve care for patients with advanced heart and lung disease. The grants were funded by […]
NEW YORK & VERO BEACH, Fla.–(BUSINESS WIRE)–NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a non-binding letter of intent (“LOI”) for a business combination with HDL Therapeutics Inc. (“HDL Therapeutics”), a privately held commercial […]
JACKSONVILLE, Fla.–(BUSINESS WIRE)–First Coast Cardiovascular Institute (FCCI) announced today that it is partnering with national cardiology platform, Cardiovascular Logistics (CVL), to enhance and expand its cardiovascular care and services throughout Northern Florida & Southern Georgia. CVL is the most comprehensive cardiovascular platform in the country. By partnering with CVL, FCCI […]
Researchers from Case Western Reserve University and University Hospitals Cleveland Medical Center (UH) have secured $6.2 million from two grants awarded in the same month from the National Institutes of Health (NIH) to predict cardiovascular disease through new artificial intelligence (AI) approaches. The study will employ cutting-edge AI techniques using machine- and deep-learning models to recognize […]
Eric Semler Appointed as Chairman SANTA CLARA, Calif., April 19, 2023 /PRNewswire/ — – Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C. Chang (together, the “Investors”), who collectively beneficially own more than 20% of Semler Scientific’s outstanding shares, will immediately join Semler Scientific’s board of directors as new independent directors. Mr. Semler […]
CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the first quarter 2023 in addition to the release of the RECOVER […]
WARRINGTON, Pa., April 20, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced the pricing of its underwritten public offering of 3,686,006 shares of common stock and warrants to purchase up to 3,686,006 shares of […]
Company Appoints De Novo Ventures Co-Founder Richard Ferrari as Chairperson, and Names Hendrik Lambert, PhD., as Chief Medical Officer BARCELONA, Spain–(BUSINESS WIRE)–Anaconda Biomed, a medical technology company developing next-generation thrombectomy systems, today announced the appointment of a new board chairperson, and the naming of a new chief medical officer. Anaconda […]
LEXINGTON, Mass., April 19, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need, today announced that it appointed […]
